Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

3.23
Delayed Data
As of 4:00pm ET
 +0.04 / +1.25%
Today’s Change
2.80
Today|||52-Week Range
14.89
-36.04%
Year-to-Date

Today’s Trading

Previous close3.19
Today’s open3.22
Day’s range3.19 - 3.45
Volume1,193,146
Average volume (3 months)2,147,076
Market cap$335.6M
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+12.43%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book4.02

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc+0.17+1.40%
SGMOSangamo BioSciences ...-0.54-9.89%
FLXNFlexion Therapeutics...+0.17+1.51%
AMRNAmarin Corporation P...+0.04+3.13%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
New York, New York

Forecasts

Partner Offers